AB1183 Patient's education in the administration of subcutaneous drugs in the rheumatology day-care hospital units. (15th June 2017)

• Record Type: Journal Article
• Authors: Erra, A; Fagil, A; Lόpez, L
• Is Part Of: Annals of the rheumatic diseases. Volume 76(2017)Supplement 2
• Page Start: 1469
• Page End: 1470
• Publication Date: 2017-06-15
• Subjects: Rheumatism -- Periodicals; 616.723005
• DOI: 10.1136/annrheumdis-2017-eular.3201
• Languages: English
• ISSNs: 0003-4967

Abstract

Abstract : Background: Rheumatology Day-Care Hospital Unit (DHU) is defined as a hospital care for a few hours with the objective to do diagnosis, clinical trials and/or multiple test, patient education and treatments that cannot be done in the outpatient clinic, but which do not justify the complete stay in the hospital Objectives: Analyze the number of visits that one patient needs in the Rheumatology-DHU to learn the self-administration of a subcutaneous drug. To evaluate if there are differences between the numbers of visits made in Rheumatology-DHU for the different drugs, and between the different age groups of the patients. Methods: All patients who were prescribed a subcutaneous drug (except denosumab) during the period January 2015 - December 2016 were referred to Rheumatology-DHU. The nurse gave instructions, she supervised the patient's learning and she decided if the patients needed a new control in Rheumatology-DHU. The following data were recorded: sex, age, diagnosis, drug, number of visits each patient made in Rheumatology-DHU, reason for new visit to Rheumatology-DHU in patients who had already been discharged and adherence to treatment. Results: 101 patients were visited in Rheumatology-DHU (8 were referred twice for education of different drugs). 79 were women (78%) and 22 men (22%). Mean age (MA) of 65 +/- 17 years (SD). A total of 238 visits were made in Rheumatology-DHU. Adherence to treatment was 98.2%. Six patients (5.5%) required a new referral to Rheumatology-DHU: 1 for poor adherence to treatment (ADA), 3 for skin lesions (2 MTX and 1 GOL), 2 supervise the treatment (1 CER and 1 MTX). In 9% of the patients, the education was done to a reference person and not to the patient himself. The number of visits in the Rheumatology-DHU were: 1 in 26 patients (MS of 66 +/- 19.6 years), 2 in 59 patients (MS 65 +/- 18); 3 in 13 patients (MS 64 +/- 13); 4 in 6 patients (MS 67 +/- 14); 5 in 2 patients (MS 68 +/- 17), 6 in 2 patients (MS 70 +/- 22), 9 in 1 patient (47 years). We analyzed PTH and MTX groups (because they had the highest number of patients) and we observed that in the PTH group 82% required ≤2 visits, 18%> of 2 visits. Patients in MTX group: 77% ≤2 visits and 23%>2 education visits. There weren't significant differences between the two groups (p=0.576). Conclusions: Adherence to treatment in patients who are referred to Rheumatology-DHU to learn the self-administration of a subcutaneous drug is very high. The new visits in Rheumatology-DHU for doubts or side effects were few. Patients on PTH treatment, who were older, didn't require a higher number of visits or more new referrals to Rheumatology-DHU. Therefore, age is not a limiting factor for the right learning of patients. The patient's education by nurse in Rheumatology-DHU is necessary for the right control of our patients Disclosure of Interest: None declared